facebook
twitter
search
search

Eli Lilly may drop inhaled insulin plan

March 8, 2008 at 12:01 PM

CAMBRIDGE, Mass., March 8 (UPI) -- Eli Lilly and Co. has pulled the plug on a collaboration with a Massachusetts company to develop inhaled insulin for diabetics.

Alkermes Inc. said it received a letter Friday from Lilly terminating the development and license agreement for AIR Inhaled Insulin. The announcement was made shortly after Alkermes released a statement that Lilly was evaluating its business case for the drug.

AIR Insulin is being evaluated in a broad phase-3 clinical trial program with patients with type 1 and type 2 diabetes. Alkermes said it was not aware of any safety, efficacy or manufacturing issues that would lead to the termination of the agreement.

Like Us on Facebook for more stories from UPI.com  
Topics: Eli Lilly
Latest Headlines